Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.

Chow CK, Thakkar J, Bennett A, Hillis G, Burke M, Usherwood T, Vo K, Rogers K, Atkins E, Webster R, Chou M, Dehbi HM, Salam A, Patel A, Neal B, Peiris D, Krum H, Chalmers J, Nelson M, Reid CM, Woodward M, Hilmer S, Thom S, Rodgers A.

Lancet. 2017 Mar 11;389(10073):1035-1042. doi: 10.1016/S0140-6736(17)30260-X. Epub 2017 Feb 10.

PMID:
28190578
2.

The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.

Greathouse MK, Weir MR.

Postgrad Med. 2012 Mar;124(2):40-52. doi: 10.3810/pgm.2012.03.2535. Review.

PMID:
22437214
3.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
4.

Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.

Stanton AV, Gradman AH, Schmieder RE, Nussberger J, Sarangapani R, Prescott MF.

Hypertension. 2010 Jan;55(1):54-60. doi: 10.1161/HYPERTENSIONAHA.109.135772. Epub 2009 Nov 16.

5.

BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.

Schrader J, Bramlage P, L├╝ders S, Thoenes M, Schirmer A, Paar DW.

Clin Drug Investig. 2007;27(11):783-96.

PMID:
17914897
6.

Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

Baguet JP, Legallicier B, Auquier P, Robitail S.

Clin Drug Investig. 2007;27(11):735-53.

PMID:
17914893
8.

A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

Baguet JP, Robitail S, Boyer L, Debensason D, Auquier P.

Am J Cardiovasc Drugs. 2005;5(2):131-40.

PMID:
15725044
9.

Angiotensin II antagonists for hypertension: are there differences in efficacy?

Conlin PR, Spence JD, Williams B, Ribeiro AB, Saito I, Benedict C, Bunt AM.

Am J Hypertens. 2000 Apr;13(4 Pt 1):418-26.

PMID:
10821345
10.

Clinical overview of irbesartan: expanding the therapeutic window in hypertension.

Man in't Veld AJ.

J Hypertens Suppl. 1997 Dec;15(7):S27-33.

PMID:
9532518

Supplemental Content

Loading ...
Support Center